Results 71 to 80 of about 25,915 (168)

Ethambutol Population Pharmacokinetics and Pharmacodynamics From a Phase 3 Confirmatory Trial for the Treatment of Tuberculosis. [PDF]

J Infect Dis
Alkhafaji S, Yang E, Lee K, Chang VK, Phillips PPJ, Nahid P, Dorman SE, Weiner M, Kurbatova EV, Bryant K, Carr W, Engle ML, Nhung NV, Nsubuga P, Diacon A, Dooley KE, Chaisson RE, Swindells S, Savic RM, AIDS Clinical Trial Group and the Tuberculosis Trials Consortium.   +19 more
europepmc   +1 more source

Macrolide-resistant <i>Mycobacterium avium</i> complex pulmonary disease: A narrative review. [PDF]

J Clin Tuberc Other Mycobact Dis
Cumar Y, Forsman LD, Schön T, Wejse C, Dahl VN.   +4 more
europepmc   +1 more source

Encoded metabolic remodeling amplifies drug resistance in Mycobacterium tuberculosis. [PDF]

PLoS Pathog
Frey AM, Babunovic GH, Culviner PH, Wang X, Meirav E, Gan M, Zhu J, Moody DB, Liu Q, Fortune SM.   +9 more
europepmc   +1 more source

A Rare Dual Complication of First-Line Anti-tubercular Therapy: A Case Report of Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome and Ethambutol-Induced Optic Neuropathy. [PDF]

Cureus
Kundu K, Alazzawi A.
europepmc   +1 more source

Global and Regional Patterns of Drug Resistance and Treatment Regimens in Spinal Tuberculosis: A Systematic Review and Meta-Analysis. [PDF]

Global Spine J
Rajasekaran S, Gurusamy G, Shetty AP, Kanna RM, Bicholkar AU, Sathwik N, Bindu Vasanthi N, Gogul SP, Gandhi AP, Vv G, Kaviprawin M.   +10 more
europepmc   +1 more source

Multipronged Cell Wall-Targeting Converts Ineffective Antibiotics into a Potent Regimen against Mycobacterium abscessus. [PDF]

ACS Infect Dis
Pee CJE, Santos MD, Pethe K.
europepmc   +1 more source

Pharmacokinetics and Dose Optimization of Ethambutol in Children on First-Line Antituberculosis Therapy: An Individual Patient Data Meta-Analysis. [PDF]

J Infect Dis
Chung TK, Yang E, Shin M, Solans BP, Zhou X, Hwang S, Yoon MC, Purohit D, Yang D, Mouksassi S, Béranger A, Bekker A, Kwara A, Panjasawatwong N, Savic RM.   +14 more
europepmc   +1 more source

Ethionamide versus ethambutol-containing first-line regimens for TB meningitis. [PDF]

Antimicrob Agents Chemother
Chen X, Ruiz-Gonzalez CE, Masias-Leon Y, Singh M, Shambles M, Peloquin CA, Jain SK.   +6 more
europepmc   +1 more source

<i>Mycobacterium marinum</i> Infection: A Clinical Case Report and 5-Year Systematic Literature Review (2021-2025). [PDF]

Clin Cosmet Investig Dermatol
Yang X, Chai S, Han Y, Wei A.
europepmc   +1 more source

Growth arrest of Mycobacterium tuberculosis in acidic environments enhances their survival of antibiotic treatment. [PDF]

PLoS Biol
Chung ES, Johnson WC, Kamkaew M, Fitzgerald TA, McNellis ME, Smith TC, Vijay S, Thuong NTT, Tan S, Aldridge BB.   +9 more
europepmc   +1 more source